Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jaquelyn T. Zoine, Kristopher A. Knight, Lauren C. Fleischer, Kathryn S. Sutton, Kelly C. Goldsmith, Christopher B. Doering & H. Trent Spencer. (2019) Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model. OncoImmunology 8:8.
Read now
Read now
Jessie Thalmensi, Elodie Pliquet, Christelle Liard, Marie Escande, Thomas Bestetti, Marion Julithe, Anna Kostrzak, Anne-Sophie Pailhes-Jimenez, Emanuèle Bourges, Maria Loustau, Julien Caumartin, Abderrahim Lachgar, Thierry Huet, Simon Wain-Hobson & Pierre Langlade-Demoyen. (2016) Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. OncoImmunology 5:3.
Read now
Read now
Rajesh K Sharma, Zinal S Chheda, Venkatakrishna R Jala & Bodduluri Haribabu. (2015) Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy. Expert Review of Vaccines 14:4, pages 537-549.
Read now
Read now
Maryann E. Mikucki, Daniel T. Fisher, Amy W. Ku, Michelle M. Appenheimer, Jason B. Muhitch & Sharon S. Evans. (2013) Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity. International Journal of Hyperthermia 29:5, pages 464-473.
Read now
Read now
Denise Nardelli-Haefliger, Pedro Romero & Patrice Jichlinski. (2012) What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?. OncoImmunology 1:2, pages 242-243.
Read now
Read now
Sharon S. Evans, Daniel T. Fisher, Joseph J. Skitzki & Qing Chen. (2008) Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress. International Journal of Hyperthermia 24:1, pages 67-78.
Read now
Read now
Joseph J. Skitzki, Jason B. Muhitch & Sharon S. Evans. (2007) Tracking the Elusive Lymphocyte: Methods of Detection during Adoptive Immunotherapy. Immunological Investigations 36:5-6, pages 807-827.
Read now
Read now
Articles from other publishers (53)
Maria Alvanou, Memnon Lysandrou, Panayota Christophi, Nikoleta Psatha, Alexandros Spyridonidis, Anastasia Papadopoulou & Evangelia Yannaki. (2023) Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming. Cancers 15:7, pages 1935.
Crossref
Crossref
Fan Zhang, Jiayu Liang, You Lu, Yongquan Tang, Shengzhuo Liu, Kan Wu, Fuxun Zhang, Yiping Lu, Zhihong Liu & Xianding Wang. (2022) Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma. Journal of Inflammation Research Volume 15, pages 6275-6292.
Crossref
Crossref
Manasi P. Jogalekar, Ramya Lakshmi Rajendran, Fatima Khan, Crismita Dmello, Prakash Gangadaran & Byeong-Cheol Ahn. (2022) CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments. Frontiers in Immunology 13.
Crossref
Crossref
Xiupeng Ye, Meijing Liu, Cuicui Lv, Yeqiong Li, Lan Chen, Jin Zhang, Juan Mu & Qi Deng. (2022) Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo. Technology in Cancer Research & Treatment 21, pages 153303382211332.
Crossref
Crossref
Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, Sandrine Haghiri, Claire Gervais, Sandy Joaquina, Joerg Mittelstaet, Nadine Mockel-Tenbrinck, Ali Kinkhabwala, Diane Damotte, Audrey Lupo, Mathilde Sibony, Marco Alifano, Elisabetta Dondi, Nadège Bercovici, Alain Trautmann, Andrew D. Kaiser & Emmanuel Donnadieu. (2021) CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1. Cancer Immunology Research 9:12, pages 1425-1438.
Crossref
Crossref
Meijing Liu, Haobin Deng, Juan Mu, Qing Li, Yedi Pu, Yili Jiang, Qi Deng & Zhengzi Qian. (2021) Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma. Cancer Science 112:7, pages 2642-2651.
Crossref
Crossref
Natalia Timofeeva & Varsha Gandhi. (2021) Ibrutinib combinations in CLL therapy: scientific rationale and clinical results. Blood Cancer Journal 11:4.
Crossref
Crossref
Bin Zhang, Youpeng Wang, Ziyin Zhao, Bing Han, Jinbo Yang, Yang Sun, Bingyuan Zhang, Yunjin Zang & Huashi Guan. (2021) Temperature Plays an Essential Regulatory Role in the Tumor Immune Microenvironment. Journal of Biomedical Nanotechnology 17:2, pages 169-195.
Crossref
Crossref
A.A.S. Batista, B.M. Franco, M.M. Perez, E.G. Pereira, T. Rodrigues, M.L. Wroclawski, F.L.A. Fonseca & E.R. Suarez. (2021) Decreased levels of cathepsin Z mRNA expressed by immune blood cells: diagnostic and prognostic implications in prostate cancer. Brazilian Journal of Medical and Biological Research 54:10.
Crossref
Crossref
Emmanuel M. Gabriel, Minhyung Kim, Daniel T. Fisher, Colin Powers, Kristopher Attwood, Sanjay P. Bagaria, Keith L. Knutson & Joseph J. Skitzki. (2020) Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma. Scientific Reports 10:1.
Crossref
Crossref
L.C. Cutmore, N.F. Brown, D. Raj, S. Chauduri, P. Wang, J. Maher, Y. Wang, N.R. Lemoine & J.F. Marshall. (2020) Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma. Pancreatology 20:3, pages 394-408.
Crossref
Crossref
Valérie Dutoit, Denis Migliorini & Pierre-Yves Dietrich. (2019) Current strategies for vaccination in glioblastoma. Current Opinion in Oncology 31:6, pages 514-521.
Crossref
Crossref
Wen Xu, Xinjian Zhang, Xinlei Hu, Chen Zhiyi & Pintong Huang. (2019) Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations. Cancer Letters 460, pages 86-95.
Crossref
Crossref
Yu-Feng Wei, Chang-Yao Chu, Chao-Chun Chang, Sheng-Hsiang Lin, Wu-Chou Su, Yau-Lin Tseng, Chien-Chung Lin & Yi-Ting Yen. (2018) Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma. Lung Cancer 125, pages 35-42.
Crossref
Crossref
Alba Yanguas, Saray Garasa, Álvaro Teijeira, Cristina Aubá, Ignacio Melero & Ana Rouzaut. (2018) ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes. Frontiers in Immunology 9.
Crossref
Crossref
Anthony Visioni, Minhyung Kim, Chandler Wilfong, Asher Blum, Colin Powers, Daniel Fisher, Emmanuel Gabriel & Joseph Skitzki. (2018) Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model. Journal of Immunotherapy 41:7, pages 313-318.
Crossref
Crossref
Michelle M. Appenheimer & Sharon S. Evans. 2018. Thermoregulation: From Basic Neuroscience to Clinical Neurology Part I. Thermoregulation: From Basic Neuroscience to Clinical Neurology Part I
397
415
.
Kari L. Ring, Anna V. Yemelyanova, Pamela T. Soliman, Michael M. Frumovitz & Amir A. Jazaeri. (2017) Potential immunotherapy targets in recurrent cervical cancer. Gynecologic Oncology 145:3, pages 462-468.
Crossref
Crossref
Zinal S. Chheda, Rajesh K. Sharma, Venkatakrishna R. Jala, Andrew D. Luster & Bodduluri Haribabu. (2016) Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors. The Journal of Immunology 197:5, pages 2016-2026.
Crossref
Crossref
Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nunez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael Milone, Simon F. Lacey, Anthony Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill & Mariusz A. Wasik. (2016) The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research 22:11, pages 2684-2696.
Crossref
Crossref
Guan-Min Jiang, Wei Xu, Jun Du, Kun-Shui Zhang, Qiu-Gui Zhang, Xiao-Wei Wang, Zhi-Gang Liu, Shuang-Quan Liu, Wan-Ying Xie, Hui-Fang Liu, Jing-Shi Liu & Bai-Ping Wu. (2016) The application of the fibroblast activation protein α-targeted immunotherapy strategy. Oncotarget 7:22, pages 33472-33482.
Crossref
Crossref
Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O'Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao & Steven M. Albelda. (2016) Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer. Clinical Cancer Research 22:2, pages 436-447.
Crossref
Crossref
Joseph M. Cantor. 2016. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy
127
161
.
Saar Gill & Carl H. June. (2015) Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunological Reviews 263:1, pages 68-89.
Crossref
Crossref
André-René Blaudszun, Gerhard Moldenhauer, Marc Schneider & Anja Philippi. (2015) A photosensitizer delivered by bispecific antibody redirected T lymphocytes enhances cytotoxicity against EpCAM-expressing carcinoma cells upon light irradiation. Journal of Controlled Release 197, pages 58-68.
Crossref
Crossref
Danny N. Khalil, Sadna Budhu, Billel Gasmi, Roberta Zappasodi, Daniel Hirschhorn-Cymerman, Tamar Plitt, Olivier De Henau, Dmitriy Zamarin, Rikke B. Holmgaard, Judith T. Murphy, Jedd D. Wolchok & Taha Merghoub. 2015. Immunotherapy of Cancer. Immunotherapy of Cancer
1
68
.
Saar Gill & Michael Kalos. 2015. Translating Gene Therapy to the Clinic. Translating Gene Therapy to the Clinic
281
304
.
Anna Dimberg. (2014) The glioblastoma vasculature as a target for cancer therapy. Biochemical Society Transactions 42:6, pages 1647-1652.
Crossref
Crossref
Elisa Peranzoni, Ana Rivas-Caicedo, Houcine Bougherara, Hélène Salmon & Emmanuel Donnadieu. (2013) Positive and negative influence of the matrix architecture on antitumor immune surveillance. Cellular and Molecular Life Sciences 70:23, pages 4431-4448.
Crossref
Crossref
Olga Salnikova, Kai Breuhahn, Natalie Hartmann, Jan Schmidt & Eduard Ryschich. (2013) Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancer. International Journal of Cancer 133:10, pages 2372-2382.
Crossref
Crossref
Rajesh Kumar Sharma, Zinal Chheda, Venkatakrishna Rao Jala & Bodduluri Haribabu. (2013) Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity. The Journal of Immunology 191:6, pages 3462-3470.
Crossref
Crossref
Michael J. Bradaric, Krishna Penumatsa, Animesh Barua, Seby L. Edassery, Yi Yu, Jacques S. Abramowicz, Janice M. Bahr & Judith L. Luborsky. (2013) Immune Cells in the Normal Ovary and Spontaneous Ovarian Tumors in the Laying Hen (Gallus domesticus) Model of Human Ovarian Cancer. PLoS ONE 8:9, pages e74147.
Crossref
Crossref
Michael Kalos & Carl H. June. (2013) Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology. Immunity 39:1, pages 49-60.
Crossref
Crossref
Saar Gill & Michael Kalos. (2013) T cell-based gene therapy of cancer. Translational Research 161:4, pages 365-379.
Crossref
Crossref
N R West, S E Kost, S D Martin, K Milne, R J deLeeuw, B H Nelson & P H Watson. (2012) Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. British Journal of Cancer 108:1, pages 155-162.
Crossref
Crossref
Cailin Moira Wilke, Shuang Wei, Lin Wang, Ilona Kryczek, Jingyuan Fang, Guobin Wang & Weiping Zou. 2013. Cancer Immunotherapy. Cancer Immunotherapy
17
44
.
Jan Emmerich, John B. Mumm, Ivan H. Chan, Drake LaFace, Hoa Truong, Terrill McClanahan, Daniel M. Gorman & Martin Oft. (2012)
IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without
De Novo
Infiltration from Secondary Lymphoid Organs
. Cancer Research 72:14, pages 3570-3581.
Crossref
Crossref
Karin Edsparr, Per H. Basse, Ronald H. Goldfarb & Per Albertsson. (2010) Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation. Cancer Microenvironment 4:3, pages 351-360.
Crossref
Crossref
Daniel T. Fisher, Qing Chen, Joseph J. Skitzki, Jason B. Muhitch, Lei Zhou, Michelle M. Appenheimer, Trupti D. Vardam, Emily L. Weis, Jessica Passanese, Wan-Chao Wang, Sandra O. Gollnick, Mark W. Dewhirst, Stefan Rose-John, Elizabeth A. Repasky, Heinz Baumann & Sharon S. Evans. (2011) IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. Journal of Clinical Investigation 121:10, pages 3846-3859.
Crossref
Crossref
Edmund K. Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S. Wang, Veena Kapoor, Jarrod Predina, Daniel J. PowellJr.Jr., James L. Riley, Carl H. June & Steven M. Albelda. (2011) Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor. Clinical Cancer Research 17:14, pages 4719-4730.
Crossref
Crossref
Vita S. Salsman, Kevin K. H. Chow, Donald R. Shaffer, Huseyin Kadikoy, Xiao-Nan Li, Claudia Gerken, Laszlo Perlaky, Leonid S. Metelitsa, Xiuhua Gao, Meena Bhattacharjee, Karen Hirschi, Helen E. Heslop, Stephen Gottschalk & Nabil Ahmed. (2011) Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment. PLoS ONE 6:5, pages e20267.
Crossref
Crossref
Michele L. Martin, Erika M. Wall, Emily Sandwith, Adam Girardin, Katy Milne, Peter H. Watson & Brad H. Nelson. (2009) Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model. Breast Cancer Research and Treatment 121:3, pages 753-763.
Crossref
Crossref
Matthew R. Farren, Louise M. Carlson & Kelvin P. Lee. (2009) Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression. Immunologic Research 46:1-3, pages 165-176.
Crossref
Crossref
Terry J. Fry & Arjan C. Lankester. (2010) Cancer Immunotherapy: Will Expanding Knowledge Lead to Success in Pediatric Oncology?. Hematology/Oncology Clinics of North America 24:1, pages 109-127.
Crossref
Crossref
Frederick Klauschen, Masaru Ishii, Hai Qi, Marc Bajénoff, Jackson G Egen, Ronald N Germain & Martin Meier-Schellersheim. (2009) Quantifying cellular interaction dynamics in 3D fluorescence microscopy data. Nature Protocols 4:9, pages 1305-1311.
Crossref
Crossref
Ju Han Song, Seung Hyun Kim, Daeho Cho, Il-Kwon Lee, Hyeoung-Joon Kim & Tae Sung Kim. (2009) Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2. International Journal of Cancer 125:5, pages 1074-1081.
Crossref
Crossref
Thorsten R. Mempel & Christian A. Bauer. (2008) Intravital imaging of CD8+ T cell function in cancer. Clinical & Experimental Metastasis 26:4, pages 311-327.
Crossref
Crossref
W. Nicholas Haining, Jeffrey Davies, Holger Kanzler, Linda Drury, Thomas Brenn, John Evans, Jill Angelosanto, Steven Rivoli, Kate Russell, Suzanne George, Paul Sims, Donna Neuberg, Xiaochun Li, Jeffrey Kutok, Jeffrey Morgan, Patrick Wen, George Demetri, Robert L. Coffman & Lee M. Nadler. (2008) CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans. Clinical Cancer Research 14:17, pages 5626-5634.
Crossref
Crossref
Terry J. Fry & Arjan C. Lankester. (2008) Cancer Immunotherapy: Will Expanding Knowledge Lead to Success in Pediatric Oncology?. Pediatric Clinics of North America 55:1, pages 147-167.
Crossref
Crossref
Soldano Ferrone & Theresa L. Whiteside. (2007) Tumor Microenvironment and Immune Escape. Surgical Oncology Clinics of North America 16:4, pages 755-774.
Crossref
Crossref
Erika M. Wall, Katy Milne, Michele L. Martin, Peter H. Watson, Patty Theiss & Brad H. Nelson. (2007) Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells. Cancer Research 67:13, pages 6442-6450.
Crossref
Crossref
L Sanchez-Perez, M Gough, J Qiao, U Thanarajasingam, T Kottke, A Ahmed, J M Thompson, R Maria Diaz & R G Vile. (2007) Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells. Gene Therapy 14:13, pages 998-1009.
Crossref
Crossref
Francine Blei. (2006) Literature Watch. Lymphatic Research and Biology 4:4, pages 229-242.
Crossref
Crossref